|View printer-friendly version|
|September 14, 2012 2:31 a.m.|
|Bayer HealthCare to acquire U.S. animal health business from Teva Pharmaceutical Industries|
SHAWNEE, Kan. and
"We are pleased with the sale of our animal healthcare business to
If approved, the acquisition will further strengthen Bayer's food animal franchise, bringing a range of anti-infective solutions to treat infections in livestock populations and introducing reproductive hormones to Bayer's product offerings. Additionally, it will broaden Bayer HealthCare Animal Health's growing companion animal business by expanding its current offerings to also include dermatological, pet wellness and nutraceutical products.
"Bayer's acquisition of
Teva Animal Health's portfolio of companion animal products features a full line of dermatology products sold under the DVM Pharmaceuticals brand, including such products as Malaseb, HyLyt, Relief and others. The companion animal business also has a broad line of nutraceuticals encompassing joint and gastro-intestinal products, including the Synovi brands. Food animal products acquired from Teva include a broad range of anti-infectives, in addition to parasiticides, anti-inflammatory brands and reproductive hormones such as Prostamate and Ovacyst.
Find more information at www.animalhealth.bayerhealthcare.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by
Denise Bradley, +1-215-591-8974, Denise.Bradley@tevapharm.com or Staci Gouveia, +1-913-268-2577, firstname.lastname@example.org